Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCAIS-I: Bevifibatide in Acute Ischemic Stroke
NCT06712004Phase 2Recruiting
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Feb 2025
- Primary completion
- Sep 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bevifibatide in ischemic stroke, sponsored by Southern Medical University Zhujiang Hospital. Started Feb 2025; status: recruiting.
02
Drugs
bevifibatide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06712004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06712004.